General Provisions Clause Example from Business Contracts
This example General Provisions clause appears in 32 contracts from 17 companies
Underwriting Agreement, dated as of January 25, 2019, by and between Interpace Diagnostics Group, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 29, 2019)
Underwriting Agreement (Filed With SEC on January 16, 2019)
Underwriting Agreement, dated April 10, 2019, by and between PolarityTE, Inc. and Cantor Fitzgerald & Co (Filed With SEC on April 11, 2019)
Underwriting Agreement, dated February 12, 2020, by and between PolarityTE, Inc. and Cantor Fitzgerald & Co (Filed With SEC on February 14, 2020)
Underwriting Agreement, dated April 12, 2018, by and between PolarityTE, Inc. and Cantor Fitzgerald & Co (Filed With SEC on April 13, 2018)
Underwriting Agreement, dated June 5, 2018, by and between PolarityTE, Inc. and Cantor Fitzgerald & Co (Filed With SEC on June 7, 2018)
Underwriting Agreement, dated April 4, 2019, by and between InspireMD, Inc. and H.C. Wainwright & Co., LLC, as Representative of the Several Underwriters (Filed With SEC on April 4, 2019)
Underwriting Agreement, dated February 27, 2018, by and between InspireMD, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on February 28, 2018)
Underwriting Agreement, dated March 28, 2018, by and between InspireMD, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 29, 2018)
Underwriting Agreement, dated June 13, 2019, by and between Navidea Biopharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on June 17, 2019)
Underwriting Agreement, dated May 30, 2019 among Aptose Biosciences Inc., RBC Capital Markets, LLC and Canaccord Genuity LLC (Filed With SEC on May 30, 2019)
Underwriting Agreement, dated December 16, 2019 between Aptose Biosciences Inc. and Piper Jaffray & Co (Filed With SEC on December 17, 2019)
Underwriting Agreement, dated July 15, 2020, between Aptose Biosciences Inc. and Piper Sandler & Co (Filed With SEC on July 16, 2020)
Underwriting Agreement, dated September 19, 2019, by and among the Company and Raymond James & Associates, Inc. and Oppenheimer & Co. Inc., as representatives of the several... (Filed With SEC on September 20, 2019)
Underwriting Agreement, dated April 22, 2020, by and among the Company and Raymond James & Associates, Inc. and Oppenheimer & Co. Inc., as representatives of the several... (Filed With SEC on April 24, 2020)
Underwriting Agreement, dated December 13, 2018, by and among the Company and BMO Capital Markets Corp., Canaccord Genuity LLC and Oppenheimer & Co., Inc., as representatives of... (Filed With SEC on December 17, 2018)
Amended and Restated Underwriting Agreement, dated July 27, 2020, between Allena Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on July 29, 2020)
Amended and Restated Underwriting Agreement, dated December 1, 2020, between Allena Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 3, 2020)
Underwriting Agreement, dated as of August 11, 2020 by and among Pacific Biosciences of California, Inc., Morgan Stanley & Co. LLC and Cowen and Company, LLC (Filed With SEC on August 14, 2020)
Underwriting Agreement, dated as of November 10, 2020 by and among Pacific Biosciences of California, Inc., Morgan Stanley & Co. LLC and Cowen and Company, LLC, and the Selling... (Filed With SEC on November 13, 2020)
Underwriting Agreement, dated as of January 24, 2023 by and among Pacific Biosciences of California, Inc. and Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, and Cowen and... (Filed With SEC on January 27, 2023)
Underwriting Agreement, dated as of September 11, 2018, by and among Pacific Biosciences of California, Inc., Cowen and Company, LLC and Cantor Fitzgerald & Co (Filed With SEC on September 14, 2018)
Underwriting Agreement, dated as of February 13, 2018, by and between Pacific Biosciences of California, Inc. and Cantor Fitzgerald & Co (Filed With SEC on February 15, 2018)
Amended and Restated Underwriting Agreement, dated August 24, 2020, between NanoVibronix, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on August 26, 2020)
Amended and Restated Underwriting Agreement, dated September 22, 2020, between NanoVibronix, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on September 24, 2020)
Underwriting Agreement, dated February 8, 2021, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on February 11, 2021)
Underwriting Agreement (Filed With SEC on February 26, 2021)
Amended and Restated Underwriting Agreement, dated July 22, 2021, between AzurRx BioPharma, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on July 27, 2021)
Amended and Restated Underwriting Agreement, dated November 23, 2021, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on November 29, 2021)
Underwriting Agreement, dated December 2, 2021, between Esperion Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 7, 2021)
Placement Agency Agreement, dated September 17, 2018, by and between ReShape Lifesciences Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on September 20, 2018)